Geode Capital Management’s Enlivex Therapeutics ENLV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,420
| Closed | -$10.1K | – | 4470 |
|
|
2025
Q1 | $10.1K | Hold |
10,420
| – | – | ﹤0.01% | 4430 |
|
|
2024
Q4 | $12.2K | Hold |
10,420
| – | – | ﹤0.01% | 4428 |
|
|
2024
Q3 | $17.5K | Hold |
10,420
| – | – | ﹤0.01% | 4412 |
|
|
2024
Q2 | $14.8K | Hold |
10,420
| – | – | ﹤0.01% | 4501 |
|
|
2024
Q1 | $39.5K | Hold |
10,420
| – | – | ﹤0.01% | 4367 |
|
|
2023
Q4 | $28.1K | Hold |
10,420
| – | – | ﹤0.01% | 4458 |
|
|
2023
Q3 | $16.5K | Hold |
10,420
| – | – | ﹤0.01% | 4659 |
|
|
2023
Q2 | $27.4K | Hold |
10,420
| – | – | ﹤0.01% | 4615 |
|
|
2023
Q1 | $37.9K | Hold |
10,420
| – | – | ﹤0.01% | 4580 |
|
|
2022
Q4 | $40K | Hold |
10,420
| – | – | ﹤0.01% | 4654 |
|
|
2022
Q3 | $44K | Hold |
10,420
| – | – | ﹤0.01% | 4790 |
|
|
2022
Q2 | $47K | Hold |
10,420
| – | – | ﹤0.01% | 4784 |
|
|
2022
Q1 | $58K | Hold |
10,420
| – | – | ﹤0.01% | 4777 |
|
|
2021
Q4 | $65K | Hold |
10,420
| – | – | ﹤0.01% | 4812 |
|
|
2021
Q3 | $102K | Buy |
+10,420
| New | +$102K | ﹤0.01% | 4668 |
|